|
TODAY'S HEADLINES
When researchers studied mortality from conditions with skin manifestations in developed versus developing countries, they found living in the developed world doesn't always translate to lower death rates. Age-adjusted mortality for melanoma, for example, was about five times greater in the developed world than in developing countries. » Read the findings
|
ADVERTISEMENT
Steroid Responsive Dermatoses & Severe Recalcitrant Nodular Acne
In this webinar, Mark Kaufmann, MD will discuss with you potential benefits of Promius Pharma's specialized distribution platform & an authorized generic version of one of its products.
 Sign up today!
|
|
An advisory committee for the Food and Drug Administration has voted to support approval of AIN457 (secukinumab, Novartis) for the treatment of moderate-to-severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy. » Get the details
|
|
fyi...
|
8.6% |
|
Number of physicians who give healthcare reform an "A" in 2014 Source: Medicus Firm
|
|
|
The Food and Drug Administration has approved a Supplemental New Drug Application for the expanded use of Lymphoseek for lymphatic mapping in all solid tumors. The approval also adds sentinel lymph node detection for melanoma and breast cancer. »Read about the approval
|
|
An expert in pediatric eczema offers insight on alternative eczema therapies to which he gives a "thumbs up," "jury's out" or a "thumbs down." » Read the options
|
|
|
Like
Tweet
